Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited.
about
New oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney diseaseFactor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillationInterventions for preventing post-operative atrial fibrillation in patients undergoing heart surgeryOral anticoagulants versus antiplatelet therapy for preventing stroke and systemic embolic events in patients with atrial fibrillationFactor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillationSonothrombolysisEvaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic SubstrateLeft Atrial Appendage: Physiology, Pathology, and Role as a Therapeutic TargetDiagnosing Paroxysmal Atrial Fibrillation: Are Biomarkers the Solution to This Elusive Arrhythmia?Mechanism of and therapeutic strategy for atrial fibrillation associated with diabetes mellitus--LAA Occluder View for post-implantation Evaluation (LOVE)--standardized imaging proposal evaluating implanted left atrial appendage occlusion devices by cardiac computed tomography.Intensity of Left Atrial Spontaneous Echo Contrast as a Correlate for Stroke Risk Stratification in Patients with Nonvalvular Atrial FibrillationDirect Thrombin Inhibitors Prevent Left Atrial Remodeling Associated With Heart Failure in RatsEpidemiology, diagnosis, and management of atrial fibrillation in womenAssociation between left atrial low-voltage area, serum apoptosis, and fibrosis biomarkers and incidence of silent cerebral events after catheter ablation of atrial fibrillation.EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.Lone atrial fibrillation: where are we now?The use of cardiac magnetic resonance imaging in the diagnostic workup and treatment of atrial fibrillation.Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference.Atrial high-rate episodes and stroke prevention.Increased Thromboembolic Events With Dabigatran Compared With Vitamin K Antagonism in Left Ventricular Assist Device Patients: A Randomized Controlled Pilot TrialLeft atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48.Antiplatelet Therapy Combinations and Thrombogenicity in Patients with Non-Valvular Atrial Fibrillation.Atrial fibrillation and the risk of myocardial infarction.The CHADS2 score predicts ischemic stroke in the absence of atrial fibrillation among subjects with coronary heart disease: data from the Heart and Soul Study.Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectivesA Non-Surgeon's Guide to Surgical Management of Atrial Fibrillation.Hemostatic markers are associated with the risk and prognosis of atrial fibrillation: the ARIC study.Is clopidogrel better than aspirin following breakthrough strokes while on aspirin? A retrospective cohort studyFine particulate air pollution (PM2.5) and the risk of acute ischemic stroke.Predictive value of atrial high-rate episodes for arterial stiffness and endothelial dysfunction in dual-chamber pacemaker patients.Relationship of CHA2DS2-VASc and CHADS2 score to left atrial remodeling detected by velocity vector imaging in patients with atrial fibrillationFactors associated with ischemic stroke on therapeutic anticoagulation in patients with nonvalvular atrial fibrillation.Peripheral arterial disease and risk of atrial fibrillation and stroke: the Multi-Ethnic Study of Atherosclerosis.Genetics of atrial fibrillation and possible implications for ischemic stroke.Height loss caused by bent posture: a risk factor for stroke from ENT clinic - is it time to reconsider the physical examination?Association of hemostatic markers with atrial fibrillation: a meta-analysis and meta-regression.Atrial Fibrillation and Risk of ST-Segment-Elevation Versus Non-ST-Segment-Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) StudyRole of inflammation in atrial fibrillation pathophysiology and management.Left atrial appendage exclusion for atrial fibrillation
P2860
Q24192938-E26AE585-D5FF-41A7-ADA2-7064D8A8143EQ24200497-06A6A95A-1462-4BE0-B1D1-A71E4D26CEB6Q24201618-6F4679FB-A5A4-4DF0-86DB-415DB426A53CQ24203797-4B038B93-7949-47D6-A6AF-AD1E278187B8Q24234397-2BC34547-C193-4140-8F13-5457B50B1E50Q26781198-B17B3F0F-DF4D-473D-A6E7-325E058E2D7CQ26799163-B4121437-5EFE-48CE-B086-363E91384945Q26799847-F1E31C15-2E49-444C-9A6E-53733D9AC44DQ26800991-96410328-CFF0-4A0F-B270-9F3730C566DAQ27014826-D68AA0B2-725F-446B-931B-FA2B7642719DQ27312052-B3ED9C5B-720E-44AE-83D4-B93022788202Q27342869-4C147D12-21D2-43E1-BA57-06FE33FC1E19Q28068706-1ABBD583-1312-44B6-AA71-25145C354145Q28083655-E8C237FC-B4E9-4BF4-9526-26814B2B1182Q30316481-B4188A19-06E5-4756-A286-4C68FAE3D654Q30375302-63D40E89-294C-4CF8-BAC7-829AA922573BQ30409016-B8B621E6-FB2F-42AF-B0DB-1DE355B24AF9Q30459988-554185BC-0ECB-47D8-B1CF-76337778B382Q30663685-27098949-72F6-4A04-9C7C-077A27DC5A05Q33589724-D5225D54-B89C-4527-86E2-FFA7B45DD46BQ33698353-25DC548A-15BA-4C3E-AB0E-D741CB19EAEAQ33722721-3A4C5C6F-C476-42B6-ACE9-769DF417E17DQ33740815-ECA34C29-04B5-48E6-940D-07F902FE698EQ33970602-8E63EC20-45E3-46F1-BFE5-2720E9E52A65Q34008166-C8086CE1-ABC2-47E4-A8FB-9C48C77913CAQ34159834-3F5CF2E5-4F3F-40EC-A82F-02C62448B552Q34398295-8799B698-5F3D-47D3-9FDC-D297BD674E75Q34512403-01FBF180-9D8D-4CF8-BAAA-C075CD7CAB7BQ34635205-D2C51F34-9355-4316-9205-21A8FE23DD90Q35008806-BFE84AED-B957-4D22-B585-1AD837E83334Q35013190-D730BC79-CC2A-4ED1-87E4-3EC7A099BC09Q35023297-958BC55B-A3CE-4282-BA20-7078BCFE3A46Q35086064-9075DD88-7AA0-4CB8-9EB3-F7D09CA6D419Q35115018-9DADE5E8-F5FA-4ADB-956F-C886F208AF93Q35142380-32F81F31-EA9F-4B75-A48D-6CA3483393D3Q35496750-E00BCCEF-FB52-437E-BDB2-59F9C08C3C1CQ35605552-7B2B2FB0-D46D-42D8-B498-A4E0A9E70698Q35661109-A526A45E-D282-4955-AB39-6C041DAF2A32Q35688023-CB99A80C-6AD8-49EE-B42C-F986CF056CCAQ35691402-E9CAC066-FBF9-4BC7-9C1A-7783968F7272
P2860
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited.
@ast
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited.
@en
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited.
@nl
type
label
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited.
@ast
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited.
@en
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited.
@nl
prefLabel
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited.
@ast
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited.
@en
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited.
@nl
P1433
P1476
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited.
@en
P2093
Eduard Shantsila
Timothy Watson
P304
P356
10.1016/S0140-6736(09)60040-4
P407
P577
2009-01-01T00:00:00Z